AIm: Pituitary adenomas do not have a single factor of aggressive behavior or recurrence. The objective of this study was to determine factors influencing the prognosis in pituitary adenomas. mATERIAL and mETHods: 243 patients who were operated between January 2000 and June 2012 were included in this retrospective study. Demographic data, age at diagnosis, date of diagnosis, date of operation, type of operation, post-operative medications, pre-and postoperative hormone levels, and MRI findings were evaluated in each patient.
Prognostic Factors Obtained from long-Term Follow-up of Pituitary Adenomas and Other Sellar Tumors

Hipofiz Adenomları ve Diğer Sellar Tümörlerin Uzun Süreli Takiplerinden Elde Edilen Prognostik Faktörler
INTRODUCTION
Tumors within the bony complex of sella turcica are the third most common primary brain tumors after gliomas and meningiomas. Pituitary adenomas constitute 10-15% of all primary brain tumors and 85% of all sellar tumors. Pituitary adenomas are followed by craniopharyngiomas, meningiomas, Rathke cleft cysts, and other sellar region mass lesions in frequency (18, 19) .
Although pituitary adenomas are slowly growing benign tumors, some exceed the sella and invade optic chiasm, cavernous sinus, sphenoid sinus and other neighboring regions (3) . Adenomas with invasion may also infiltrate the bone and much rarely the brain. There is no single parameter to predetermine which pituitary adenoma will exhibit aggressive behavior or recurrence. However, studies have demonstrated that the prognosis might depend on patient age and sex, tumor type and size, cavernous sinus invasion and basal hormone levels in pituitary adenomas (17) .
The objective of this study was to investigate demographic data, post-operative hormonal remission, recurrence, residual tissue, and re-operation rates in relation to patient age and sex, tumor type and size, optic nerve compression, cavernous sinus invasion, and hormone levels in order to determine prognostic factors in sellar tumors.
MATERIALS and METHODS
Study Design
Medical records of 243 patients who were operated by the Department of Neurosurgery and followed by the Department of Endocrinology of Erciyes University Medical School (EUMS) between January 2000 and June 2012 were investigated in this retrospective study after the local ethic committee approval. All patients were operated by the same neurosurgeon. Name, surname, age, sex, date of diagnosis, age at diagnosis, date of operation, type of operation, postoperative medications, pre-and post-operative hormone levels and magnetic resonance imaging (MRI) findings of the patients were recorded.
Patients
Study inclusion criteria were being older than 16 years, having hormone examinations before and after the operation, having MRI reports in the pre-or post-operative period, performance of immunohistochemical staining of hormone secreting or non-functioning pituitary adenomas by the Pathology department of EUMS. Exclusion criteria were being younger than 16 years, absence from post-operative follow-up visits including hormonal and radiological examination.
Hormonal Assessment
Basal levels of hormones were determined in the pre-operative and post-operative period. Additionally, various dynamic tests were performed when necessary to determine hormonal remission, recurrence or hormonal failure. Basal hormone levels including free T4 (normal: 0.88-1.72 ng/dL), thyroid stimulating hormone (TSH, normal: 0.57-5.6 mIU/mL), adrenocorticotropic hormone (ACTH, normal: 0-46 pg/mL), cortisol (normal: 9-23 μg/dL), prolactin (normal: 2-18 ng/mL), follicle stimulating hormone (FSH), luteinizing hormone (LH), total testosterone (in males), estradiol (in females), and insulin-like growth factor-1 (IGF-1, reference intervals by age: 219-644 ng/mL for 18-30 years, 140-405 ng/mL for 31-40 years, 64-336 ng/mL for 41-50 years, 71-284 ng/mL for 51-60 years, 94-269 ng/mL for 61-70 years, 72-167 ng/mL for 71-80 years) were measured in the laboratories of EUMS.
Methods of assays, commercial kits, and intraassay and interassay coefficients of variations were GH: immunoradiometric assay (IRMA), Immunotech sas-France, 1.5% and 14%, IGF-1: IRMA, Immunotech sas-France, 6.3% and 6.8%, and cortisol: radioimmunoassay (RIA), Immunotech s.r.o-Czech Republic, 5.8% and 9.2%. Other hormone levels were measured with either one of the routinely used RIA, IRMA or chemiluminassay methods. Their commercial kits, and intra-interassay coefficients of variations were ACTH: Cisbio Bioassays-France, 6.1-5.3%, prolactin: Siemens Advia centaur XP-USA, 2.6-4.0%, TSH: Siemens Advia centaur XP-USA, 2.48-5.31%, fT4: Siemens Advia centaur XP-USA, 3.33-2.50%, FSH: Siemens Advia centaur XP-USA, 2.9-2.7%, LH: Siemens Advia centaur XP-USA, 2.3-1.5%, estradiol: Siemens Advia centaur XP-USA, 11.1-2.0%, total testosterone: DIAsource immunoassays S.A.-Belgium, 4.6-6.2%.
Post-operative hormonal remission was defined as normal IGF-1 levels by age and sex in acromegaly. Additionally, GH response to 75 gr. oral glucose testing was evaluated in patients with IGF-1 level higher than the upper limit of normal range. Post-operative hormonal remission was defined as regression of serum PRL level to normal values in prolactinoma. Similarly, the definition proposed that cortisol response to stimulation with low dose 2 mg dexamethasone suppression test (DST) should be lower than 1.8 μg/dL in Cushing's disease.
Gonadotropin deficiency in pituitary failure was established by reduced basal testosterone and estradiol levels below the lower limit of normal range despite normal or decreased gonadotropin levels. TSH deficiency was diagnosed by reduced free T4 levels despite normal or decreased TSH levels. Serial cortisol measurements were performed following the intravenous administration of 1 μg tetracosactrin (Synacthen, Novartis Pharma, Lion, France) in low dose ACTH stimulation testing. Adrenal failure was defined as determination of peak cortisol levels below 18 μg as a result of the latter testing. GH deficiency was diagnosed with the insulin tolerance test (ITT). Limit value of peak GH level was determined as <3 μg/L for GH deficiency in ITT. The diagnosis of ADH deficiency was established by evaluating serum and urine osmolalities and the response to desmopressin therapy in patients with polydipsia and polyuria.
Assessment of Recurrence
Recurrence in hormone secreting adenomas was defined as repeated increase in basal hormone levels following attain- 
Immunohistochemical Evaluation
Operation materials of sellar tumors were examined by the Pathology department of EUMS. All tissues were bathed in 10% formaldehyde for 24 hours and subjected to routine tissue tracing procedures. Cross-sections of 0.4 microns were obtained following paraphine embedding. These cross-sections were stained with hematoxylin-eosin and evaluated with Olympus microscope. PRL, TSH, GH, ACTH, FSH, and LH stains were administered in each case.
Radiological Evaluation
Three-dimensional volumetric pituitary MRIs (Philips GyroscanIntera 1.5 Tesla; Best, Netherlands) were obtained in the pre-operative and post-operative follow-up of the patients at the Radiology department of EUMS. Tumor size, cavernous sinus infiltration, optic chiasm compression, and residual tissues were evaluated in pre-operative and post-operative MRI reports of the patients. Tumors < 10 mm were evaluated as microadenoma, tumors ≥ 10 mm as macroadenoma, and macroadenomas ≥ 40 mm as giant adenoma.
Statistical Evaluation
Descriptive statistics included mean, standard deviation, frequency and ratio. Homogeneity of the variances was tested in the variables. T-test and ANOVA (Tukey test in subgroup analyses) were used as parametric tests. Chi-square test was used in the analysis of ratios, and Fischer's Test was used when Chisquare did not comply. All statistical analyses were performed with the SPSS 15.0 software. All analyses were performed within 95% confidence interval. A p value of <0.05 was considered statistically significant.
RESULTS
Of the 243 patients included in the study 79 had acromegaly, 75 had nonfunctioning pituitary adenoma, 42 had prolactinoma, 7 had Cushing's disease, 2 had Thyrotropinoma (TSHoma), 15 had craniopharyngioma, 12 had meningioma, and 11 had other sellar tumors. In the latter group of other sellar tumors there were 3 Rathke cleft cysts, 3 metastases (plasmacytoma, endometrial sarcoma and lung carcinoma metastases), 2 astrocytomas, 2 chordomas, and 1 germinoma. The mean age at diagnosis was 42.5± 13.4 years in male patients and 32± 15.8 years in female patients with prolactinoma, and no significant differences were found between males and females regarding the mean age at diagnosis (Table I ).
There were only 34 (14%) microadenomas and the remaining 209 cases (86%) were macroadenomas for a total of 243 (Figure 1 ). Total resection rate was 9.1% in the 77 cases with tumor diameter greater than 3 cm and 47.6% in the 166 cases with tumor diameter smaller than 3 cm when the relationship between tumor diameter and total resection rates was evaluated in the entire study population (p=0.001).
Pre-operative cavernous sinus invasion was most common in cases with prolactinoma and TSHoma, and optic chiasm compression was most common in cases with nonfunctioning pituitary adenoma. The highest rates of post-operative improvement in cavernous sinus invasion and optic chiasm compression were observed in cases with acromegaly cases in our study. Giant adenomas constituted 27 (36%) of nonfunctioning pituitary adenomas, 7 (46%) of craniopharyngiomas, and 5 (45%) of other sellar tumors. Within the group of secretory pituitary adenomas, prolactinomas were the most common group of giant adenomas. Eleven (26%) of the prolactinomas were giant adenomas (Table II) . The rate of hormonal remission was 73.5% in microadenomas and 43.5% in macroadenomas when the relationship between sellar tumor size and prognosis was assessed (p= 0.001). Additionally, the rate of total resection was 85.3% in microadenomas and 27.3% in macroadenomas (p= 0.0001), with the re-operation rates lower in cases with microadenomas. On the other hand, post-operative residual tissue was determined in 60 (80%) nonfunctioning pituitary adenomas, 31 (74%) prolactinomas, and 39 (49.4%) acromegaly cases (Table III) .
Accordingly, the total resection rate was 35.6% and 36.3% in cases with pituitary adenomas and other sellar tumors, 
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Hormonal remission could be attained despite post-operative residual tissue in 9 acromegaly cases, and one of each of prolactinoma, Cushing's disease, and TSHoma cases.
In the evaluation of rates of post-remission recurrence, the recurrence rates were 41.1% in prolactinoma cases with a mean follow-up of 36.5 months (3-138 months), and 11.4% in acromegaly cases with a mean follow-up of 48 months (1-138 months) . Additionally, enhancement in tumor size or novel adenoma formation in residual tumor was observed in 18.6% of nonfunctioning pituitary adenoma cases with a mean follow-up of 30 months (3-115 months). Recurrence was statistically significantly most common in prolactinomas among all pituitary adenomas.
( Figure 2 ). Pre-operative optic chiasm compression was the most predominant in non-secretory sellar tumors among all sellar tumors. The phenomenon was determined in 89% of nonfunctioning pituitary adenomas, 91% of meningiomas, and 60% of craniopharyngiomas. Among all secretory pituitary tumors, patients with prolactinoma presented with the highest rates of optic chiasm compression (65%). Surgical success in removing optic chiasm compression was statistically higher than the surgical success in removing cavernous sinus invasion in all sellar tumors (Table IV) .
Post-operative hormonal remission rates were 62% in patients with acromegaly and 71.4% in patients with Cushing's disease. However, post-operative hormonal remission could be attained in only 40.4% of patients with prolactinoma.
Figure 2:
Percentiles of preoperative cavernous sinus invasion in sellar tumors. Acromegaly: 37%, nonfunctioning pituitary adenoma 75%, prolactinoma 81%, Cushing's disease 0%, TSHoma 50%, craniopharyngioma 66%, meningioma 75%, and other tumors: 82%. Tumor Type
Percentile
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850 ng/mL. Hormonal remission was compared in these two subgroups of acromegaly cases and the results were statistically significant (p= 0.002). Additionally, recurrence rates were higher in patients with an IGF-1 level > 850 ng/ml, although not to a statistically significant degree (p= 0.151). However, cavernous sinus invasion, residual tissue and reoperation rates were significantly higher in patients with IGF-1 levels > 850 ng/mL.
Age and prognosis were not significantly associated in the prolactinoma cases. However, in the assessment of prognostic importance of gender, hormonal remission was more common in the female prolactinoma patients (p= 0.048). In terms of tumor size, hormonal remission was more common in cases with microadenomas compared to those with macroadenomas (p= 0.029). Additionally, the amount of residual tissue was greater in macroadenomas (p= 0.03).
In the evaluation of the relationship between cavernous sinus invasion and prognosis, hormonal remission was less common in prolactinoma cases with compared to those without cavernous sinus invasion (p= 0.003). The rate of residual tissue was also higher in prolactinoma cases with cavernous sinus invasion (p= 0.009).
The relationship between prognosis and tumor size was investigated in nonfunctioning pituitary adenoma cases and it was noted that rates of post-operative residual tissue and re-operation were higher in cases with giant nonfunctioning adenomas (p= 0.009). However, no significant increase of recurrence was determined in patients with giant nonfunctioning adenomas. Relatedly, when all patients with nonfunctioning pituitary adenoma were considered together, no relationship was found between tumor size and recurrence rates. Residual tissue and re-operation rates were higher in cases with cavernous sinus invasion in nonfunctioning adenomas. Recurrence rates were also higher in nonfunctioning adenomas with post-operative residual tissue in our study (p= 0.038). Cavernous sinus invasion was determined in 76% of nonfunctioning adenomas and recurrence was observed in 21% of those with cavernous sinus invasion and 11% of those without (p= 0.345, not significant).
The most commonly deficient hormones were gonadotropins (36%) and TSH (33%) when all sellar tumors were evaluated together. Individual assessment of each disorder demonstrated that TSH deficiency was more common in acromegaly and meningioma, and FSH-LH deficiencies were more common in the remaining tumors (Table V) . Post-operative hormonal deficiency was statistically significantly more common in nonsecretory sellar tumors compared to secretory adenomas (p= 0.001). Post-operative pituitary deficiency was most common in nonfunctioning pituitary adenomas (71%), followed by craniopharyngiomas (67%) and finally prolactinomas (60%).
When the acromegaly group was evaluated and the age at diagnosis and prognosis compared, the hormonal remission rate was lower in the 30-50 years age group, which was the most common age stratum (p= 0.06). Rates of post-operative residual tissue, recurrence, and re-operation were similarly higher in this age group in acromegaly cases, but not to a statistically significant degree. Recurrence rates were higher in females compared to males in the comparison of gender and hormonal remission with recurrence rates in acromegaly (p= 0.007). However, no correlation was determined between hormonal remission and gender (p= 0.40). In the evaluation of the relationship between tumor size and prognosis, the amount of residual tissue was greater in macroadenomas compared to microadenomas (p= 0.002). However, no significant relationship was determined between tumor size and recurrence as well as re-operation rates in the acromegaly group. Hormonal remission was less common in giant adenomas compared to other adenomas (p= 0.004). In the assessment of the prognostic importance of cavernous sinus invasion, no significant relationship was determined between cavernous sinus invasion and hormonal remission and recurrence. However, rates of residual tissue and reoperation were higher in acromegaly cases with cavernous sinus invasion compared to those without invasion (p= 0.01).
The prognostic importance of the IGF-1 level was also examined and hormonal remission was observed in 15 of 35 acromegaly cases (42.9%) with IGF-1 levels >850 ng/mL, and 34 of 44 acromegaly cases (77.3%) with IGF-1 levels ≤ (16) . Rates of remission have been reported to be higher in microprolactinoma and female prolactinoma cases in the study of Arasho et al. (2) . In our study, postoperative hormonal remission was more common in microprolactinoma cases. Similarly, post-operative hormonal remission was less common in cases with giant adenomas of acromegaly patients. However, no significant relationship was determined between tumor size and recurrence rates in cases with acromegaly and prolactinoma. The higher rates of postoperative hormonal remission in pituitary tumor cases with microadenoma compared to macroadenoma was explained with greater total resection rates in microadenomas.
Ferreira et al. have examined 117 non-functioning pituitary adenomas and determined a relationship between tumor size and recurrence, re-operation and hormonal deficiency (7) . A metaanalysis has reported no association between tumor size and recurrence in nonfunctioning adenomas (17) . Additionally, Brochier et al. have reported an association between post-operative residual tissue and recurrence (5).
Recurrence rates were higher in nonfunctioning adenomas with post-operative residual tissue in our study too.
In the study by Raverot et al. on 94 prolactinoma cases aimed at demonstrating the relationship between tumor invasion and remission, post-operative remission was determined in only 2 out of 33 cases (6%) with cavernous sinus invasion. Post-operative remission was observed in 58 of 61 (95%) patients without cavernous sinus invasion (16) . Yet another study demonstrated remission in 21.6% and 72.2% of patients with and without cavernous sinus invasion, respectively (15) . In our study, hormonal remission was higher in prolactinomas and acromegaly cases without cavernous sinus invasion, but this was not significant in the acromegaly group.
Brochier et al. have examined nonfunctioning pituitary adenomas in 142 patients and found cavernous sinus invasion in 54%. They determined recurrence in 51% and 27% of those with and without cavernous sinus invasion, respectively (5). A strong correlation has been determined between cavernous sinus invasion and recurrence in nonfunctioning pituitary adenomas in other studies and our study (1, 6, (8) (9) (10) (12) (13) (14) .
Currently, total surgical resection is known to be very difficult in cases with cavernous sinus invasion. In cases of hormonally active pituitary adenomas, residual tumor tissue from subtotal resection will continue to secrete hormones. Such tumors might exhibit aggressive behavior, recur, enlarge and even require repetitive operations despite surgical treatment. Cavernous sinus invasion should be therefore determined and classification should be performed pre-operatively in pituitary adenomas to aid substantially in planning the surgery and post-surgical treatment approaches.
Basal hormone levels might yield important information regarding the prognosis in acromegaly. (16) . Only a few studies were found in the metaanalysis of Roelfsema et al. on the effect of age at diagnosis and gender on prognosis in pituitary adenomas (17) . Similarly, no significant relationship was determined between age at diagnosis and prognosis of sellar tumors in our study. However, a substantive relationship was determined between gender and prognosis in cases of acromegaly and prolactinoma. Recurrence rates were higher in female cases of acromegaly, whereas postoperative hormonal remission was more common in female prolactinoma cases. The higher rates of remission in female patients with prolactinoma might be associated with smaller mean tumor sizes in females compared to males, and less surrounding tissue invasion, resulting in greater chances of curative surgery. (11) . The mean IGF-1 level was 631 ng/mL in remitting patients and 952.6 ng/mL in non-remitting patients in the same study. In our study, the mean IGF-1 level was 808 ±42 ng/mL in remitting acromegaly cases but 928 ± 48 ng/mL in non-remitting cases. Additionally, post-operative hormonal remission was observed in 77.3% of 44 acromegaly patients with a pre-operative IGF-1 level ≤ 850 ng/mL and 42.9% of 35 acromegaly patients with an IGF-1 level > 850 ng/mL, and this difference was statistically significant. Accordingly, the cut-off IGF-1 value might be set as 850 ng/mL rather than 825 ng/mL to pre-determine post-operative hormonal remission in patients diagnosed with acromegaly. Post-operative recurrence should be watched more closely in patients with acromegaly and an IGF-1 level above 850 ng/mL. Our results have increased the basal cut-off value of IGF-1, which has important prognostic value in acromegaly. However, there seems to be no substantial difference between the two recommended cut-off values, i.e. 825 ng/mL and 850 ng/ mL, because of the low number of our patients (6 patients) with an IGF-1 value between 800 and 851 ng/mL. Therefore, further studies should be performed on this issue.
CONCLUSIONS
The total resection rate of pituitary adenoma and other sellar tumors was less than 50% in our study. Higher total resection rates ensure a better prognosis in pituitary adenomas. Therefore, surgical success increases and the complication plus re-operation rates decrease in the presence of an experienced surgeon and surgical team. Chances of curative surgery and hence hormonal remission were low in adenomas with optic chiasm compression and cavernous sinus invasion. Cavernous sinus invasion complicates and even precludes chances of total resection. Therefore, cavernous sinus invasion might be accepted as the main prognostic factor in pituitary adenomas. Cavernous sinus invasion should be determined and classification should be performed preoperatively in pituitary adenomas in order to determine the surgical procedure and post-surgical therapies. In addition, post-operative hormonal remission might be pre-determined from basal hormone levels in acromegaly. We suggest an IGF-1 value of 850 ng/ml as a cut-off value determining hormonal remission in acromegaly.
In short, there is no single prognostic factor in sellar region tumors. The effect of the surgeon's experience on treatment is certainly undisputed. However, the long-term follow-up results of our study demonstrated that factors common to all sellar region tumors including tumor type, tumor size, total resection, and cavernous sinus invasion in addition to tumor type-specific factors including gender and hormone levels play important roles in the prognosis.
